The startup using AI to help rare disease families develop custom treatments
--------------------------------------------------------------------
Source: CNBC
Published: 2026-08-18 21:00 UTC+10:00
Section: General
Factuality Score: 90
Opinion Category: Neutral
Topics: Science, Health, Journalism, Technology & AI, Technology
--------------------------------------------------------------------
Snippet:
CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our journalism to elevate stories that advance research, innovation and patient care in rare diseases.
--------------------------------------------------------------------